Skip to content
WeighLab

Evidence review

Acid Reflux and Sulfur Burps on GLP-1 Treatment: What the Evidence Supports

The short answer

Belching and reflux are recognized adverse reactions in Wegovy and Zepbound labeling. A sulfur-like smell does not identify a diagnosis or prove dangerous stomach paralysis. Record symptoms, meal timing and treatment changes. Discuss persistent reflux with your clinician, and seek prompt care for trouble swallowing, bleeding, severe pain or repeated vomiting.

By The WeighLab Bench, Tools & Data Desk
Section index06

An unpleasant burp can be embarrassing; burning that wakes you at night can be exhausting. Neither symptom should be dismissed because a medication is helping with weight. The useful next step is to describe what is happening and decide whether you need medical assessment, a food or timing adjustment, or a review of the treatment plan.

“Sulfur burps” is a description of an odor, not a diagnosis. Internet explanations often jump from that smell to a precise cause, a promised cure or a claim of permanent stomach damage. Those conclusions require more evidence than a smell can provide.

PartnerGrade A

CoreAge Rx

$99/mo sema · $149/mo tirz

Visit CoreAge Rx
Semaglutide
$99/mo
Tirzepatide
$149/mo
Coverage
All 50 states
Brand-name
Compounded only
Modeled / yr
$1,188

CoreAge Rx charges one flat price at every dose, $99 a month for semaglutide and $149 for tirzepatide, with no membership fee.

Read the full CoreAge Rx review →

Assume any provider we list may compensate us — we may earn a commission at no cost to you. It never moves the Index. See our disclosure.

Partner

Found

92/100
Semaglutide
$199/moInsurance-linked
Tirzepatide
$289/moInsurance-linked
Visit Found

Are reflux and burping recognized side effects?

Wegovy's prescribing information lists eructation, meaning belching, and gastroesophageal reflux disease among adverse reactions. Zepbound's label also includes belching and reflux12. This supports discussing symptoms with the prescriber. It does not establish that every episode is medication-related or that one supplement will prevent it.

GLP-1 medicines can delay gastric emptying. That effect is relevant to digestion, but it does not mean everyone with burping has gastroparesis. A diagnosis requires clinical assessment. Reflux, fullness, nausea and delayed emptying overlap in ways that cannot be sorted out by an online symptom list.

Use the exact product name when asking for help. Oral Wegovy, injected Wegovy, Ozempic and compounded semaglutide should not be treated as interchangeable prescriptions. Our oral semaglutide comparison explains why formulation and indication matter.

What does a sulfur smell tell you?

It tells you what you noticed. The current labels do not provide a sulfur-burp diagnostic test, a predictable duration for that odor or a specific proven sulfur-burp treatment. Do not read a precise mechanism or treatment guarantee into the broader finding that belching occurs.

Tell the clinician whether the main problem is odor, burning, sour regurgitation, bloating, nausea or vomiting. Mention diarrhea, fever or a recent illness too. Different combinations may point toward different questions, and a symptom that first appeared during GLP-1 treatment can still have another cause.

A useful description might be: “I have sour fluid coming up after dinner and a strong-smelling burp; it began after the latest increase.” Include whether symptoms happen after a particular meal or when lying down. That is more informative than reporting “sulfur poisoning” or assuming a particular infection.

Meal size and timing: practical questions

For reflux occurring at night or while lying down, NIDDK notes that leaving at least three hours between eating and lying down may help. It also recommends discussing personally relevant food triggers, rather than assuming every person needs the same restrictive diet3.

A short food-and-symptom record can help identify a pattern. Ask whether smaller portions and slower eating are reasonable for you. Expert consensus on GLP-1 gastrointestinal symptoms supports individualized eating and tolerability advice4. These measures are not a guarantee of symptom resolution, and symptoms that persist deserve reassessment.

Avoid building a diet around a long prohibited-food list from social media. If you remove coffee, acidic foods or richer meals temporarily, record whether it changes your symptoms. Explain any reduced food intake to the clinician; a plan that controls burning by making you afraid to eat needs further attention. The protein and nutrition guide addresses the broader problem of maintaining intake when appetite is low.

Do you need an antacid or acid-suppressing medicine?

Ask a clinician or pharmacist. The appropriate product depends on the symptoms, how often they occur, your other medicines and your health history. A medication that helps acid reflux may not address every cause of belching or vomiting.

Explain what you have already tried, including over-the-counter medicines, digestive enzymes and herbal products. Do not keep adding treatments because a discussion forum says a particular brand “neutralizes sulfur.” A treatment claim should have evidence for the symptom and situation at hand, not merely a plausible-sounding explanation.

If reflux keeps returning after treatment, ask what follow-up is appropriate. Buying months of an acid-reducing drug without discussing ongoing symptoms can postpone a more useful evaluation. For a complete overview of expected effects, see the semaglutide or tirzepatide side-effect guide.

Symptoms that should not be treated as routine reflux

Difficulty or pain with swallowing, persistent vomiting, unexplained weight loss beyond the expected treatment course, and signs of gastrointestinal bleeding need medical attention. NIDDK identifies these as reasons to see a doctor5. Blood in vomit or black tar-like stools require prompt assessment.

Chest pain should not be assumed to be heartburn. Seek emergency help for possible heart-attack symptoms, including new or severe chest discomfort, particularly with shortness of breath, sweating or pain spreading to the arm or jaw. Do not use an antacid response as proof that the heart is safe.

Severe or persistent abdominal pain, repeated vomiting or inability to keep fluids down also warrant prompt assessment. The GLP-1 labels contain warnings that go beyond ordinary indigestion12. A familiar symptom name does not make every episode harmless.

Review tolerability before the next increase

Tell your prescriber if reflux is affecting sleep, meals or daily activities. Bring it up before the next planned increase rather than assuming that a schedule must proceed regardless of symptoms. Dose decisions belong in a clinical conversation; do not independently combine products, split doses or substitute a compounded formulation.

Ask how to reach the care team between visits. For a paid online program, confirm whether symptom appointments are included and whether a refill can be paused while the prescription is reassessed. Our provider-selection guide covers these questions, and provider reviews help compare published service terms.

The research library links related questions about nausea, bowel symptoms and medication interactions. Use it to prepare a focused conversation, rather than trying to diagnose a stomach disorder from an isolated burp.

Frequently asked questions

Are sulfur burps proof of gastroparesis?

No. Odor alone cannot diagnose gastroparesis. Persistent fullness, vomiting or difficulty eating should be discussed with a clinician.

Can I take an antacid with my GLP-1?

Ask a pharmacist or clinician about the specific product and your other medicines. Repeated or severe symptoms need assessment rather than indefinite self-treatment.

Will reflux go away after a few days?

There is no dependable individual timeline. Record the pattern and contact the prescriber if symptoms persist, affect eating or sleep, or worsen.

References

  1. Novo Nordisk (2026). Wegovy prescribing information, revised June 2026. Prescribing information. https://www.novo-pi.com/wegovy.pdf
  2. Eli Lilly and Company (2026). Zepbound prescribing information, revised August 2026. Prescribing information. https://pi.lilly.com/us/zepbound-uspi.pdf
  3. National Institute of Diabetes and Digestive and Kidney Diseases (2020). Eating, Diet, & Nutrition for GER & GERD. NIDDK. https://www.niddk.nih.gov/health-information/digestive-diseases/acid-reflux-ger-gerd-adults/eating-diet-nutrition
  4. Gorgojo-Martínez JJ et al. (2022). Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with GLP-1 Receptor Agonists: A Multidisciplinary Expert Consensus. Journal of Clinical Medicine. https://pubmed.ncbi.nlm.nih.gov/36614945/
  5. National Institute of Diabetes and Digestive and Kidney Diseases (2020). Symptoms & Causes of GER & GERD. NIDDK. https://www.niddk.nih.gov/health-information/digestive-diseases/acid-reflux-ger-gerd-adults/symptoms-causes

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.